Archives of Academic Emergency Medicine. 2022; 10(1): e48 OR I G I N A L RE S E A RC H Risk Factors of Readmission in COVID-19 Patients; a Ret- rospective 6-Month Cohort Study Mohammad Haji Aghajani1,2a, Reza Miri1,2a, Mohammad Sistanizad1,3, Amirmohammad Toloui4, Arian Madani Neishaboori4, Asma Pourhoseingholi1, Ziba Asadpoordezaki5,6, Roxana Sadeghi1,2∗, Mahmoud Yousefifard4,7† 1. Prevention of Cardiovascular Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Department of Cardiology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 3. Department of Clinical Pharmacy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 4. Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran. 5. Department of Psychology, Maynooth University, Kildare, Ireland. 6. Kathleen Lonsdale Institute for Human Health Research, Maynooth University, Kildare, Ireland. 7. Pediatric Chronic Kidney Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran. Received: March 2022; Accepted: May 2022; Published online: 20 June 2022 Abstract: Introduction: The available literature regarding the rate of readmission of COVID-19 patients after discharge is rather scarce. Thus, the aim in the current study was to evaluate the readmission rate of COVID-19 patients and the components affecting it, including clinical symptoms and relevant laboratory findings. Methods: In this retrospective cohort study, COVID-19 patients who were discharged from Imam Hossein hospital, Tehran, Iran, were followed for six months. Data regarding their readmission status were collected through phone calls with COVID-19 patients or their relatives, as well as hospital registry systems. Eventually, the relationship between demographic and clinical characteristics and readmission rate was assessed. Results: 614 patients were entered to the present study (mean age 58.7±27.2 years; 51.5% male). 53 patients were readmitted (8.6%), of which 47 pa- tients (7.6%) had a readmission during the first 30 days after discharge. The reasons for readmission were relapse of COVID-19 symptoms and its pulmonary complications in 40 patients (6.5%), COVID-19 related cardiovascu- lar complications in eight patients (1.3%), and non-COVID-19 related causes in five patients (0.8%). Older age (OR=1.04; 95% CI: 1.01, 1.06; p=0.002) and increased mean arterial pressure during the first admission (OR=1.04; 95% CI: 1.01, 1.08; p=0.022) were found to be independent prognostic factors for the readmission of COVID-19 patients. Conclusion: Readmission is relatively frequent in COVID-19 patients. Lack of adequate hospital space may be the reason behind the early discharge of COVID-19 patients. Hence, to reduce readmission rate, extra care should be directed towards the discharge of older or hypertensive patients. Keywords: Patient readmission; prognosis; follow-up studies; COVID-19 Cite this article as: Haji Aghajani M, Miri R, Sistanizad M, Toloui A, Madani Neishaboori A, Pourhoseingholi A, Asadpoordezaki Z, Sadeghi R, Yousefifard M. Risk Factors of Readmission in COVID-19 Patients; a Retrospective 6-Month Cohort Study. Arch Acad Emerg Med. 2022; 10(1): e48. https://doi.org/10.22037/aaem.v10i1.1514. ∗Corresponding Author: Associate Professor, Imam Hossein Hospital, Madani St., Tehran, Iran; Phone/Fax: +982173432383/77582733; E-mail: roxan.sadeghi@sbmu.ac.ir, ORCID: http://orcid.org/0000-0001-9447-8483. † Corresponding Author: Mahmoud Yousefifard; Physiology Research Cen- ter, School of Medicine, Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran 14496-14535, Iran. Tel: +98 (21) 86704771; Email: yousefi- fard.m@iums.ac.ir, ORCID: http://orcid.org/0000-0001-5181-4985. a, First and Second authors have same contribution. 1. Introduction Since December 2019 and the emergence of the “Severe Acute Respiratory Syndrome Coronavirus 2”, a novel virus from the family of coronaviruses, in Wuhan, China, until January 29, 2021, more than 102 million people have been infected, worldwide, and over 2.2 million people have died due to the disease caused by it. World Health Organization (WHO) has named the disease COVID-19, and its pandemic This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem M. Haji Aghajani et al. 2 continues to this day (1, 2). The most common organs in- volved in this disease are the lungs, and the most prevalent clinical signs are fever, cough, body aches, fatigue, and short- ness of breath. However, signs of the involvement of other organs, such as neurological, cardiovascular and renal signs, have also been reported (3, 4). The incidence of severe clini- cal signs and the severe form of the disease is higher in older people and patients with an underlying disease, compared to other patients. Death is also more frequent in these peo- ple. Hypertension due to diabetes and cardiovascular dis- eases have been reported to be the most common underlying diseases corresponding to disease severity and mortality due to COVID-19 (5-8). Considering the increasing number of COVID-19 patients, worldwide, the shortage in the number hospital beds and the crushing pressure on the health care systems are becom- ing a global crisis. In these circumstances, doctors may be prompted into early discharge of the patients, which could cause readmission of the discharged patients and eventually increase the pressure on the health care systems, even more. Moreover, several studies exist that have reported cases of readmission among COVID-19 patients (9, 10). On that ac- count, knowing the exact probability of readmission due to COVID-19 and the factors affecting it would be of great im- portance in aiding patients’ management and anticipating the treatment results. The most important reasons for read- mission in COVID-19 patients are the reoccurrence of respi- ratory symptoms or the occurrence of non-pulmonary com- plications of COVID-19, such as cardiovascular, central ner- vous system, and renal complications. In this regard, few studies exist, reporting a readmission rate of two to 19 per- cent (11-14). This versatility in the reporting rates, in addi- tion to the limited existing evidence, presents the need for further research in this field. Since the probability of readmission due to COVID-19 in the current crisis situation should be assessed precisely, our aim in the present study is to investigate the rate of readmis- sion in COVID-19 patients and the affecting factors, includ- ing clinical symptoms and related laboratory findings. 2. Methods 2.1. Study design and setting The present study is a retrospective cohort study, con- ducted on patients admitted to Imam Hossein Hospital, Tehran, Iran, between February 18, 2020 and July 20, 2020. COVID-19 infection was confirmed based on RT-PCR test. The study protocol was approved by the ethics committee of Shahid Beheshti University of Medical Sciences (code: IR.SBMU.RETECH.REC.1399.680), and the researchers ad- hered to the principles of Helsinki declaration throughout the study. 2.2. Participants In the present study, confirmed COVID-19 patients admitted to Imam Hossein hospital, who were recovered from the dis- ease and discharged, were recruited. Exclusion criteria was insufficient clinical and laboratory data, patients’ death dur- ing the first admission, and not being able to contact the pa- tient after discharge. 2.3. Data gathering In the present study, data from all COVID-19 patients, admit- ted to Imam Hossein hospital, were gathered through hos- pital registry databases. Then, mortality cases were elimi- nated. Next, based on their admission code and Iranian Na- tional Code, patients who were readmitted to Imam Hossein Hospital were identified. The data extracted from patients’ records included demographic data, history of cardiovascu- lar disease, history of other comorbidities, clinical symptoms at the time of admission, mean arterial pressure during their hospital stay, laboratory and imaging findings, and the pa- tients’ status at the time of discharge. Later on, a nurse, familiar with the data collecting process, contacted all the included patients through phone call, to ask about the readmission cases in other hospitals. In cases of no answer, a second call was made within 24 hours. If no one answered, other phone numbers in the patient’s hospital pro- file were reached. If again no one answered the call, another phone call was made, one week later, to minimize the miss- ing data. It is worth to mention that the least follow up period was six months, whereas the longest follow up timeframe was nine months. Also, the assessed outcome in our study was readmission. In the assessment of the underlying causes of readmission (either from the patients’ profile or phone call), the causes were divided into three groups: readmission due to the COVID-19 disease or respiratory complications, read- mission due to cardiovascular complications, and readmis- sion due to other causes. Readmission was defined as the re- hospitalization of COVID-19 patients who had previously re- covered from COVID-19 within 2 weeks after discharge (15). 2.4. Statistical analysis All analyses were performed using SPSS 22.0 statistical pro- gram. Quantitative data were presented as mean and stan- dard deviation (SD) or median and interquartile range, and qualitative data were reported as frequency and percent- age. Patients were classified into two groups of readmis- sion and non-readmission. Next, the relationship of demo- graphic characteristics and clinical symptoms or laboratory findings with readmission was investigated. For the compar- ison of quantitative variables, t-test or Mann-Whitney equiv- alent was used. Also, for the comparison of qualitative vari- ables, Chi-square or Fisher’s exact tests were applied. Fur- This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem 3 Archives of Academic Emergency Medicine. 2022; 10(1): e48 Figure 1: Flow diagram of the present study. thermore, the relationship between the confounding factors was assessed fitting a stepwise multivariate logistic regres- sion model to investigate the relationship between demo- graphic variables, clinical symptoms or laboratory findings and readmission. In all analyses, a p value less than 0.05 was considered significant. The prevalence of readmission was 19.9% in the study with the longest follow up design, which was two months of follow up (11). Therefore, considering the 95% confidence interval (CI) and 5% error, the minimum re- quired sample size was calculated to be 246 patients for the entire study. 3. Results During the study period, data from 991 patients had become available. Of these, 257 patients died during their hospital- ization and 734 patients were discharged. Throughout the follow up, 120 patients (16.3%) did not answer the phone call, so 614 patients entered the present study (Figure 1). The mean age of these patients was 58.7±27.2 years and 51.5% of them were male. Of these 614 patients, 53 patients were readmitted (8.6%), out of which 47 patients’ readmission (7.6%) had occurred within the first 30 days following their discharge. The median time frame between discharge and readmission was 6.5 days (with a range of 1 to 240 days). The reasons for readmission were relapse of COVID-19 symp- toms and its pulmonary complications in 40 patients (6.5%), COVID-19 related cardiovascular complications in eight pa- tients (1.3%), and non-COVID-19 related causes in five pa- tients (0.8%) (Figure 2). Univariate analyses showed that the mean age of the read- mitted patients (66.6±16.5 years) was lower than the mean age of the non-readmitted group (57.9±16.5 years) (p<0.001). Also, possible prognostic factors for the readmission of COVID-19 patients in univariate analyses included a his- tory of coronary artery diseases (p=0.013), mean arterial pressure during hospitalization (p=0.028), white blood cells count in the blood (p<0.001), lymphocyte count in the blood (p=0.004), neutrophil count in the blood (p=0.034), and the occurrence of cardiovascular accidents during hospitaliza- tion (p=0.041) (Table 1 and 2). The multivariate logistic regression model depicted that older age (OR=1.04; 95% CI: 1.01, 1.06; p=0.002) and in- creased mean arterial pressure during the first hospitaliza- tion (OR=1.04; 95% CI: 1.01, 1.08; p=0.022) were independent prognostic factors for the readmission of COVID-19 patients (table 3). This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem M. Haji Aghajani et al. 4 Table 1: Baseline characteristics of COVID-19 patients based on readmission status Variable Readmitted Total (n=614) P No (n=561) Yes (n=53) Age (year) 57.9±16.5 66.6±16.5 58.7±27.2 <0.001 Gender Female 272 (48.5) 26 (49.1) 298 (48.5) 0.937 Male 289 (51.5) 27 (50.9) 316 (51.5) BMI (kg/m2) —- 26.92±6.0 27.2±4.9 History of coronary artery disease No 408 (72.70) 30 (56.60) 438 (71.30) 0.013 Yes 153 (27.30) 23 (43.40) 176 (28.70) Length of stay —- 7.0±8.1 7.4±5.5 0.055 Vital sign Body temperature 37.0 (36.8, 37.3) 37.0 (36.9, 37.3) 37.0 (36.8, 37.3) 0.351 Heart rate (beat/min) 83.3 (79.3, 89.0) 82.7 (78.8, 89.2) 83.3 (79.3, 89.0) 0.942 SpO2 (%) 91.7 (89.7, 94.0) 91.3 (88.7, 93.8) 91.7 (89.7, 94.0) 0.393 Respiratory rate (per min) 18.7 (17.3, 21.3) 19.3 (18.0, 22.7) 18.7 (17.7, 21.6) 0.104 Mean arterial pressure (mmHg) 86.7 (81.1, 91.1) 90.0 (82.2, 95.0) 86.7 (81.1, 91.1) 0.028 Laboratory PvO2 (mmHg) 29.0 (23.3, 39.7) 30.6 (22.7, 47.1) 29.2 (23.2, 40.1) 0.531 PvCO2 (mmHg) 42.2 (37.6, 46.4) 41.7 (35.6, 45.8) 42.1 (37.5, 46.3) 0.445 WBC count 6.5 (4.9, 8.6) 8.1 (6.1, 11.7) 6.6 (5.0, 8.8) <0.001 Lymphocyte (%) 20.0 (13.1, 27.0) 16.0 (10.3, 21.4) 20.0 (13.0, 26.7) 0.004 Neutrophil (%) 73.1 (65.5, 80.0) 74.7 (69.5, 83.1) 73.3 (65.6, 80.3) 0.034 CRP (mg/L) 45.1 (19.4, 72.0) 42.1 (18.6, 66.1) 44.6 (19.2, 72.0) 0.349 Hb (gr/dL) 12.6 (11.4, 13.7) 12.2 (11.2, 13.3) 12.6 (11.4, 13.7) 0.334 RBC count 4.5 (4.1, 4.9) 4.5 (4.0, 4.8) 4.5 (4.1, 4.9) 0.646 Cr (mg/dL) 1.1 (1.0, 1.4) 1.2 (1.0, 1.7) 1.2 (1.0, 1.4) 0.135 Hematocrit (%) 37.5 (34.2, 40.5) 36.8 (33.9, 40.8) 37.5 (34.2, 40.5) 0.643 CPK (U/L) 104.0 (58.0, 222.5) 90.0 (55.8, 240.5) 103.0 (58.0, 222.0) 0.752 Cardiac dysrhythmia No 264 (52.40) 24 (49.00) 288 (52.10) 0.649 Yes 240 (47.60) 25 (51.00) 265 (47.90) Cardiac complication during hospitalization No 527 (93.90) 45 (84.90) 572 (93.20) 0.041 Yes 34 (6.10) 8 (15.10) 42 (6.80) Data are presented as mean ± standard deviation, median (percentile 25- percentile 75) and frequency (%). WBC: White blood cell; RBC: Red blood cell; CRP: C-reactive protein; Hb: Hemoglobin; Cr: Creatinine; CPK: Creatine phosphokinase. Table 2: Comparing the readmission rate based on the COVID-19 treatment protocol Treatment protocol Readmitted Total (n=614) P No (n=561) Yes (n=53) Corticosteroid + interferon + remdesivir 10 (1.80) 1 (1.90) 11 (1.80) Corticosteroid + interferon + favipiravir 13 (2.30) 0 (0.00) 13 (2.10) Corticosteroid + interferon + kaletra + HCQ 48 (8.60) 6 (11.30) 54 (8.80) Corticosteroid + interferon + kaletra 32 (5.70) 0 (0.00) 32 (5.20) interferon + kaletra + HCQ 42 (7.50) 5 (9.40) 47 (7.70) 0.290 Interferon + kaletra 27 (4.80) 3 (5.70) 30 (4.90) Kaletra + HCQ 86 (15.30) 6 (11.30) 92 (15.00) HCQ 163 (29.10) 12 (22.60) 175 (28.50) Others 140 (25.00) 20 (37.70) 160 (26.10) Data are presented as frequency (%). HCQ: hydroxychloroquine. 4. Discussion For the first time, the present study aimed to follow COVID- 19 patients for a period of six months to conclude that 8.6% of the patients discharged alive will be admitted to the hospi- tal, again. Of these, 75.5% of the readmission cases were due to the recurrence of the COVID-19 symptoms or its respira- This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem 5 Archives of Academic Emergency Medicine. 2022; 10(1): e48 Table 3: Multiple logistic regression for prediction of readmission of COVID-19 patients Variable Odds ratio 95% CI P Older age 1.04 (1.01, 1.06) 0.002 Cardiac complication during hospitalization 2.32 (0.86, 6.25) 0.095 Increase in lymphocyte (continuous) 0.96 (0.93, 1.00) 0.051 Increase in mean arterial pressure (continuous) 1.04 (1.01, 1.08) 0.022 CI: confidence interval. tory complications, and cardiovascular complications were the cause in 15.1% of the readmitted patients. The most paramount prognostic factors for readmission were older age and increased mean arterial pressure during the first hospital stay. The findings of the current study demonstrated that 67.9% of the readmissions occur during the first week following discharge. Hence, it seems that the impetuosity of health care directors in patients’ discharge could have been the pri- mary reason behind the readmissions. This matter can be at- tributed to the lack in the resources, such as hospital beds, human resources, and equipment, during the peak of the pandemic, which could have been the leading cause behind the early discharge of the patients, showing relative resolu- tion of their symptoms without complete recovery or having a negative PCR test. As a result, the primary cause of the read- missions should be considered the lack of resources, rather than medical errors. As shown in preceding studies, a great number of COVID-19 patients develop cardiovascular complications (16). There- fore, 15.1% of the readmission cases may be related to the cardiovascular complications following COVID-19. Since we showed that a history of cardiovascular comorbidities was unrelated to readmission, the cardiovascular complications that led to readmission may be due to the infection itself. The available evidence indicate that older age is an indepen- dent factor for the severity of the disease and its pertaining mortality (5, 6, 17, 18). In the present study, it was depicted that age is an independent risk factor for the readmission of COVID-19 patients as well, indicating the role of older age in the development of severe clinical symptoms and prolonged course of the disease. On the contrary, Donnelly et al., who performed a two-month follow up on COVID-19 patients and presented a 19.9% readmission rate, did not find a relation- ship between older age and readmission (11). This difference between the results of the present study and that of Donnelly et al.’s may be because of the differences between the ages of the included patients. In the current study, 22.4% of the patients were under 45 years old, while in that study, only 3.2% of the patients were under 45 years of age. Since Don- nelly et al.’s study was conducted in a much narrower range of age and their patients group consisted of a larger group of old patients, their nonsignificant results for the relationship of readmission and older age may be attributed to these two reasons. In another study by Yeo et al. the 30-day readmission rate of COVID-19 patients was evaluated (14). In this study, it was concluded that 4.5% of the patients may be readmitted dur- ing the mentioned timeframe. Meanwhile, this rate was cal- culated to be 8.6% in the present study. This difference be- tween the two rates may be attributed to the follow up strat- egy adopted in their study and that of ours. In Yeo et al ‘s study, the follow up timeframe was decided to be 30 days, while in our study this timeframe was six months. More im- portantly, in Yeo et al.’s study, readmission to other hospitals was not assessed. In other words, readmissions to a single center was evaluated in their study. Consequently, the actual rate of readmission may be underestimated in their study, because a number of the patients may be admitted to other hospitals. In the present study, this bias was prevented by contacting the patients or their relatives through phone calls, in addition to reviewing profiles of patients who were read- mitted to Imam Hossein hospital, to include readmissions to other medical centers, as well. In addition, there are stud- ies reporting a readmission rate of about 2% for COVID-19. However, their results were limited to much shorter follow up timeframes, and their results are not comparable to that of our study (12, 13). In the univariate analyses performed in Yeo et al.’s study, age and hypertension, were significantly related to the readmis- sion of COVID-19 patients, but in their multivariate analy- sis model, these two variables became non-significant in re- lation to readmission (14). In their study, stepwise models were not utilized to identify independent prognostic factors for readmission. As a result, if they would have used step- wise models, which is a more precise multivariate analysis method for identifying prognostic factors, different results would/could have been obtained. In line with the findings of the present study, Woo-Hwi et al. also concluded that older age is a risk factor for the readmission of COVID-19 patients (9). The increase in mean arterial pressure during the first admis- sion was concluded to be one of the factors contributing to readmission. Likewise, Ramirez et al. concluded that hyper- tension is associated with a greater probability of readmis- sion (10). Moreover, a significant relationship was observed This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem M. Haji Aghajani et al. 6 between hypertension and readmission in Atalla et al.’s study (19). Hypertension or higher blood pressure, is a risk factor for the severe form of COVID-19. Hence, the status of the hypertensive patients is more critical than that of other pa- tients, and their prompt discharge may result in increased chances of their readmission. 5. Limitations One of the limitations of the present study was the loss of the 120 patients during our follow up period. Nonetheless, this 16.3% loss is still lower than the 20% cut-off mentioned in the guidelines of the quality control of observational studies (20). Subsequently, the effects of this loss are rather inconsid- erable. Furthermore, the cause of readmission in 15.1% of the patients was cardiovascular accidents. Although cardiovas- cular complications are one of the prevalent complications of COVID-19, but the mentioned cardiovascular accidents may not be completely attributable to COVID-19. Eventually, the retrospective design of the present study, limited the re- searchers’ ability to investigate all of the probable risk factors and prognostic factors affecting readmission. 6. Conclusion Readmission is a relatively common phenomenon in COVID- 19 patients. The six-month follow up preformed revealed an overall readmission rate of 8.6% in COVID-19 patients, the risk of which may increase with older age and with an el- evated mean arterial pressure. It seems that the lack of re- sources may be the underlying factor for the early discharge of COVID-19 patients in the peak of the pandemic, leading to the increase in readmission probability. Therefore, it is rec- ommended that older or hypertensive patients’ discharge be performed cautiously to reduce their readmission. 7. Declarations 7.1. Acknowledgments The authors kindly appreciate all staff members of Imam Hossein Hospital who helped us to collect the data and per- form this study. 7.2. Data availability The data is at the disposal of the corresponding author of the article and it it can be made available to the researchers upon request. 7.3. Authors’ contributions Study design: MHA, MY Collecting and cleaning the data: All authors Analysis and interpretation of results: AP, AT, AMN Drafting: MY, AT, AMN Revising: All authors 7.4. Funding and supports This study was supported by Shahid Beheshti University of Medical Sciences. 7.5. Conflict of interest There is no conflict of interest. References 1. World Health Organization. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020 Genova: World Health Organization; 2020 [Available from: https://www.who.int/director- general/speeches/detail/who-director-general-s- remarks-at-the-media-briefing-on-2019-ncov-on-11- february-2020. 2. World Health O. Weekly Epidemiological Update 2020 [Available from: https://www.who.int/docs/default- source/coronaviruse/situation-reports/20201005- weekly-epi-update-8.pdf. 3. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. 4. MadaniNeishaboori A, Moshrefiaraghi D, Ali KM, Toloui A, Yousefifard M, Hosseini M. Central Nervous System Complications in COVID-19 Patients; a Systematic Re- view and Meta-Analysis based on Current Evidence. Arch Acad Emerg Med. 2020;8(1):e62. 5. Guan W-j, Liang W-h, Zhao Y, Liang H-r, Chen Z-s, Li Y-m, et al. Comorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide Analysis. Eur Respir J. 2020;55(5):2000547. 6. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054-62. 7. Emami A, Javanmardi F, Pirbonyeh N, Akbari A. Preva- lence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Arch Acad Emerg Med. 2020;8(1):e35. 8. Khateri S, Mohammadi H, Khateri R, Moradi Y. The Prevalence of Underlying Diseases and Comorbidities in COVID-19 Patients; an Updated Systematic Review and Meta-analysis. Arch Acad Emerg Med. 2020;8(1):e72. 9. Jeon W-H, Seon JY, Park S-Y, Oh I-H. Analysis of Risk Fac- tors on Readmission Cases of COVID-19 in the Republic of Korea: Using Nationwide Health Claims Data. Int J En- viron Res Public Health. 2020;17(16):5844. 10. Parra LM, Cantero M, Morras I, Vallejo A, Diego I, Jimenez-Tejero E, et al. Hospital readmissions of This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem 7 Archives of Academic Emergency Medicine. 2022; 10(1): e48 discharged patients with COVID-19. Int J Gen Med. 2020;13:1359–66. 11. Donnelly JP, Wang XQ, Iwashyna TJ, Prescott HC. Read- mission and Death After Initial Hospital Discharge Among Patients With COVID-19 in a Large Multihospital System. JAMA. 2021;325(3):304-6. 12. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hos- pitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-9. 13. Somani SS, Richter F, Fuster V, De Freitas JK, Naik N, Sigel K, et al. Characterization of patients who return to hospi- tal following discharge from hospitalization for COVID- 19. J Gen Intern Med. 2020;35(10):2838-44. 14. Yeo I, Baek S, Kim J, Elshakh H, Voronina A, Lou MS, et al. Assessment of Thirty-Day Readmission Rate, Timing, Causes, and Predictors after Hospitalization with COVID- 19. J Intern Med.290(1):157-65. 15. Ramzi ZS. Hospital readmissions and post-discharge all- cause mortality in COVID-19 recovered patients; A sys- tematic review and meta-analysis. Am J Emerg Med. 2022;51:267-79. 16. SeyedAlinaghi S, Afsahi AM, MohsseniPour M, Behnezhad F, Salehi MA, Barzegary A, et al. Late Com- plications of COVID-19; a Systematic Review of Current Evidence. Arch Acad Emerg Med. 2021;9(1):e14. 17. Zali A, Gholamzadeh S, Mohammadi G, Looha MA, Akrami F, Zarean E, et al. Baseline Characteristics and As- sociated Factors of Mortality in COVID-19 Patients; an Analysis of 16000 Cases in Tehran, Iran. Arch Acad Emerg Med. 2020;8(1):e70. 18. Gholamzadeh S, Mohammadi G, Looha MA, Akrami F, Zarean E, Vafaee R, et al. Baseline Characteristics and As- sociated Factors of Mortality in COVID-19 Patients; an Analysis of 16000 Cases in Tehran, Iran. Arch Acad Emerg Med. 2020;8(1):e70-e. 19. Atalla E, Kalligeros M, Giampaolo G, Mylona EK, She- hadeh F, Mylonakis E. Readmissions among Patients with COVID-19. Int J Clin Pract. 2020;75(3):e13700. 20. Health NIo. Study Quality Assessment Tools| National Heart, Lung, and Blood Institute (NHLBI) United States: National Institutes of Health; 2014 [Available from: https://www.nhlbi.nih.gov/health-topics/study- quality-assessment-tools. This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem M. Haji Aghajani et al. 8 Figure 2: Readmission rate among COVID-19 patients based on the time of readmission (A) and cause of readmission (B). COVID-19 relapse: Relapse of COVID-19-related symptoms or its respiratory complication. This open-access article distributed under the terms of the Creative Commons Attribution NonCommercial 3.0 License (CC BY-NC 3.0). Downloaded from: http://journals.sbmu.ac.ir/aaem Introduction Methods Results Discussion Limitations Conclusion Declarations References